These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2857283)

  • 1. HTLV-III antibodies in haematology staff.
    Jones P; Hamilton P
    Lancet; 1985 Jan; 1(8422):217. PubMed ID: 2857283
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and risk of transmission of HTLV III infections to staff at a London hospital, 1982-85.
    Shanson DC; Evans R; Lai L
    J Hosp Infect; 1985 Dec; 6 Suppl C():15-22. PubMed ID: 2868048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Lancet; 1984 Nov; 2(8411):1094. PubMed ID: 6150160
    [No Abstract]   [Full Text] [Related]  

  • 4. HTLV-III seropositivity in AIDS.
    Behan WM; Burt AD
    Lancet; 1984 Jun; 1(8389):1292. PubMed ID: 6144989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of anti-HTLV-III antibodies in gammaglobulin preparations for intramuscular injection].
    Scheiermann N; Gesemann M; Riffelmann HD
    Dtsch Med Wochenschr; 1985 Dec; 110(49):1912-3. PubMed ID: 2415316
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of HTLV-III antibodies in homosexual men in Johannesburg.
    Sher R; dos Santos L
    S Afr Med J; 1985 Mar; 67(13):484. PubMed ID: 2984794
    [No Abstract]   [Full Text] [Related]  

  • 7. What proportion of HTLV-III antibody positives will proceed to AIDS?
    Moss AR
    Lancet; 1985 Jul; 2(8448):223-4. PubMed ID: 2862413
    [No Abstract]   [Full Text] [Related]  

  • 8. [A simple method for determination of antibodies to AIDS associated virus (HTLV-III)].
    Biberfeld G; Bredberg-Rådén U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
    Lakartidningen; 1984 Sep; 81(39):3482-3. PubMed ID: 6092800
    [No Abstract]   [Full Text] [Related]  

  • 9. [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report].
    Arosemena JR; Cuevas M; Ulloa E; Guerrero DM; Gómez B; Cantón-Dutary A; Reyes R; Quiroz E; de Britton RM; Brenes MM
    Rev Med Panama; 1986 May; 11(2):124-33. PubMed ID: 3018847
    [No Abstract]   [Full Text] [Related]  

  • 10. What Delaware's physicians should know about HTLV-III antibody testing.
    Silverman PR; Verma MP; Olsen LJ
    Del Med J; 1985 May; 57(5):331-2. PubMed ID: 2993049
    [No Abstract]   [Full Text] [Related]  

  • 11. LAV/HTLV-III in 20-week fetus.
    Jovaisas E; Koch MA; Schäfer A; Stauber M; Löwenthal D
    Lancet; 1985 Nov; 2(8464):1129. PubMed ID: 2865600
    [No Abstract]   [Full Text] [Related]  

  • 12. An indirect fluorescent antibody test for antibodies against HTLV-III.
    Sher R; Lyons S; dos Santos L; Schoub B; McGillivray G
    S Afr Med J; 1985 Mar; 67(10):357. PubMed ID: 2984791
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to HTLV I and III in sera from two Japanese patients, one with possible pre-AIDS.
    Aoki T; Miyakoshi H; Usuda Y; Chermann JC; Barré-Sinoussi F; Ting RC; Gallo RC
    Lancet; 1984 Oct; 2(8408):936-7. PubMed ID: 6148658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Human T-lymphotropic retrovirus and AIDS. HTLV-III is probably the cause of acquired immunodeficiency syndrome].
    Dobloug JH
    Tidsskr Nor Laegeforen; 1985 Jan; 105(1):50-2. PubMed ID: 2982219
    [No Abstract]   [Full Text] [Related]  

  • 15. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
    Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
    J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
    [No Abstract]   [Full Text] [Related]  

  • 16. HTLV positivity in Africans.
    Hunsmann G; Schneider J; Wendler I; Fleming AF
    Lancet; 1985 Oct; 2(8461):952-3. PubMed ID: 2865454
    [No Abstract]   [Full Text] [Related]  

  • 17. Sero-epidemiology of HTLV-III antibody in southern Africa.
    Lyons SF; Schoub BD; McGillivray GM; Sher R
    S Afr Med J; 1985 Jun; 67(24):961-2. PubMed ID: 2988142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The surgeon and HTLV-III infection.
    Forbes CD
    Br J Surg; 1986 Mar; 73(3):168-9. PubMed ID: 3004628
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute illnesses associated with HTLV-III seroconversion.
    Farthing C; Gazzard B
    Lancet; 1985 Apr; 1(8434):935-6. PubMed ID: 2858784
    [No Abstract]   [Full Text] [Related]  

  • 20. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.